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Abstract
Aim: The association of sodium (Na) and potassium (K) intake with blood pressure (BP) is an ongoing debate, espe-
cially in central Iran. We aimed to examine the mean Na and K intake, major sources of Na and the relationship
between BP and dietary and urinary Na and K.
Methods: This cross-sectional study was performed in central Iran in 2013–2014. A total of 796 non-hypertensive
adults aged >18 years were randomly recruited. The semi-quantitative food frequency questionnaire was used to
assess dietary Na and K intake. Moreover, 24-hour urine samples were collected to measure 24-hour urinary Na
(UNa) and K (UK) as biomarkers. BP was measured twice on each arm using a standard protocol.
Results: The mean Na and K intake were 4309.6  1344.4 and 2732.7  1050.5 mg/day, respectively. Table and
cooking salt were the main sources of Na. Odds ratio (OR) (95% conﬁdence interval (CI)) of the crude model in the
highest quartile of UNa indicated a signiﬁcant association with the higher risk of prehypertension (OR (95% CI): 2.09
(1.09–4.05); P for trend = 0.007). After adjustment for potential confounders, prehypertension was signiﬁcantly
associated with increasing dietary Na/K ratio (OR (95% CI): 1.28 (1.01–1.57); P for trend = 0.046) and UNa/UK ratio
(OR (95% CI): 2.15(1.08-4.55); P for trend = 0.029).
Conclusions: Increasing dietary and urinary Na/K ratios and UNa were associated with elevated BP and prehyperten-
sion occurrence. These ﬁndings support the necessity of developing a salt reduction programme in our country.
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Introduction
Hypertension is a major public health issue affecting almost
one quarter of adults worldwide. Its prevalence is on a
rapid rise in developing countries1 and has reached 17.3%
among Iranian adult population.2 Hypertension control
has, hence, turned into a global public health priority.3 Die-
tary modiﬁcations may regulate blood pressure (BP) and
subsequently control hypertension.4 Among dietary factors,
high sodium (Na) and low potassium (K) intakes are associ-
ated with higher BP5 and have been reported to increase
overall mortality and the risk of cardiovascular diseases in
the American population.6 Na reduction may thus be the
most cost-effective approach to hypertension control in
both low- and high-income countries.7 Although several
epidemiological and interventional studies have shown BP
to be independently associated with Na and K levels,8,9 a
population-based study rejected the relationship between K
levels and BP.8 However, two recent meta-analyses on
22 randomised clinical trials (RCTs) and population-based
studies in 21 countries reported an inverse relationship
between K levels and BP.10,11 While most studies have
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measured Na and K intake through dietary assessment
methods, such as 24-hour dietary recall or semi-quantitative
food frequency questionnaire (FFQ), evaluating the urinary
excretion of Na and K using 24-hour urine collection is still
considered the most valid and reliable method to determine
daily intake of these two elements.12 Furthermore,
population-based studies have failed to establish obvious
relationships between Na and K levels and hypertension.
Because of the ongoing debate over these relationships,13,14
especially in Eastern Mediterranean and Middle East
regions, the present study aimed to evaluate the associa-
tions between dietary Na and K intake and BP using data
from the Isfahan salt study in 2013–2014.15
Methods
The present study was performed on healthy adults aged
>18 years in Isfahan city, Iran in 2013–2014. In order to
select the participants using multi-stage cluster sampling, a
number of households were ﬁrst selected, and the study
objectives and procedures were explained to them. One
adult from each household was then recruited. Sample size
was determined according to a previous study,15 and a total
of 796 healthy individuals were enrolled. While the only
inclusion criteria was age greater than 18 years, the exclu-
sion criteria were a history of diabetes insipidus, diabetes
mellitus, hypertension, a special dietary regimen or fasting
at the time of sampling, history of using diuretics, renal
insufﬁciency, menstruation or pregnancy and excessive
sweating on the day of urine collection. In addition, we
excluded the participants with less than 500 mL urine/day,
reporting more than one missed voiding. Male and female
subjects who were younger than 50 years with 24-hour
urine creatinine (UCr) to body weight ratios of less than
20 and 15 mg/kg/day, respectively, along with those who
were aged 50 years and over with UCr to body weight
ratios of less than 10 and 7.5 mg/kg/day, respectively. The
study was approved by the Research Council of Isfahan
Cardiovascular Research Centre (ICRC), a World Health
Organization (WHO) collaborative centre, ethics committee.
Written informed consent was obtained from all partici-
pants. This paper was prepared based on the strengthening
the reporting of observational studies in epidemiology
(STROBE) statement for cross-sectional studies.
The medical history of all subjects was taken, and clinical
examinations followed by blood and urine tests were per-
formed. Height and weight were measured using standard
methods. Body mass index (BMI) was calculated as weight
divided by height squared (kg/m2). BP was measured man-
ually by a trained operator using a mercury sphygmoma-
nometer according to standard protocol,16 twice from right
and left arms in sitting position after ﬁve minutes of rest.
We kept the BP measurement environment silent to hear
Korotkoff sound. The ﬁrst Korotkoff sound was recorded as
the systolic blood pressure (SBP), and the disappearance of
the sounds (V phase) was considered the diastolic blood
pressure (DBP). The mean of the two BP readings on the
arm with higher BP was used in the analyses. According to
the Joint National Committee7 (JNC7) and WHO guide-
lines, prehypertension was deﬁned as an SBP of
130–139 mmHg and/or a DBP of 80–89 mmHg.1
Dietary assessment was carried out by a 136-item semi-
quantitative FFQ. The FFQ was validated against the gold
standards of 24-hour urine samples and 12-monthly 24-
hour dietary recalls in 113 participants. The FFQ was also
recompleted with a one-year interval to examine its repro-
ducibility. The criterion validity and reproducibility were
presented by correlation and intra-class correlation coefﬁ-
cients, respectively. The criterion validity of FFQ for assess-
ment of Na and K was 0.60 and 0.56 compared with 24-
hour dietary recall and 0.31 and 0.38 against 24-hour urine
Na and K excretions, respectively. The reproducibility was
0.43 and 0.40 for Na and K intake, respectively. The FFQ
was coded by giving a gram weight to every portion
reported. All dietary data were entered into the Iranian
Food Consumption Program (IFCP), designed by ICRC,17
and analysed. The IFCP calculated nutrient intake and food
group servings for all foods reported in the FFQ. It had a
research quality nutrient database analysing Na and K for a
variety of food items using the Iranian Food Composition
Table,18 which was modiﬁed based on the US Department
of Agriculture National Nutrient Database. Trained nutri-
tionists assisted in the design and validation of the dietary
questionnaire. The FFQ included some questions about die-
tary supplements and ﬁve questions regarding discretionary
salt consumption, including salt used at the table and salt
for food preparation at home. The salt intake questions
comprised using the salt shaker, the weight of the salt pack-
age that they usually use, how long before the salt package
was consumed, the total number of family members and
their age to estimate salt consumption by each participant.
Urine samples were collected from 7 a.m. to 7 a.m. the
next day (after excluding the ﬁrst sample of the ﬁrst day).
The samples were poured into sterile plastic containers
labelled with the participants’ name and a special code.
Inappropriately collected samples along with those with a
low volume of urine were excluded from the analysis. If a
person was unable to deliver the urine sample to the labora-
tory, we collected it at his/her home. Venous blood samples
were taken on the same day to measure serum biochemical
indices, including fasting blood sugar, serum albumin level
and lipid proﬁle. Total 24-hour urinary Na (UNa) was cal-
culated by multiplying Na concentration by the urine vol-
ume in litres. Urinary chemical parameters including UNa,
24-hour urinary K (UK) and 24-hour UCr were measured.
In order to assess the accuracy of urinary samples as 24-
hour specimens, we measured the concentration of UCr
using Jaffe method (technical SMA 12-60).
Categorical variables were presented as frequencies,
mean and standard deviations were used to summarise the
values of continuous variables. As our data were fairly com-
plete, a simple approach (i.e. complete-case) was adopted
to handle missing data. Chi-square and Student’s t-tests
were used to compare baseline characteristics between nor-
motensive and prehypertensive participants. As the percent-
age of food contribution in Na intake was not normally
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distributed, we utilised a Mann–Whitney U test to compare
the two groups. An analysis of variance (ANOVA) test was
applied to compare the mean of normally distributed vari-
ables. In cases where the data did not have a normal distri-
bution, Kruskal–Wallis tests in UNa, UK and UNa/UK ratio
quartiles were used.
Hierarchical logistic regression was used to determine
effect sizes according to different categories of confounders.
In fact, simple logistic regression was ﬁrst ﬁtted to evaluate
the crude relationships between prehypertension and the
quartiles of dietary and urinary Na, K and Na/K ratio. Mul-
tiple logistic regression was then applied to ﬁnd the
adjusted associations, considering the reference category as
those at the ﬁrst quartile. The initial adjusted model was
deﬁned to comprise age and gender as covariates (Model
1). We ﬁtted Model 2 to assess additional adjustment for
BMI (kg/m2). The confounder effect of 24-hour UCr
(mg/day) was additionally adjusted in Model 3. Using the
median of dietary and urinary Na, K and Na/K ratio in each
quartile in the logistic models, the trend of odds ratios
(ORs) were evaluated by ﬁnding the P values for each
trend. Statistical analyses were performed using SPSS for
windows 18.0 (SPSS Inc, Chicago, IL, USA). The signiﬁ-
cance level was set at P < 0.05.
Results
The study sample included 796 individuals (349 men
and 447 women). As Table 1 shows, the mean Na and K
dietary intake and Na/K ratios in all participants were
4309.6  1344.4, 2732.7  1050.5 mg/day and 1.6 
0.8, respectively. The mean 24-hour UNa, UK and UNa/UK
ratios in the whole population were 4069.6  1655.3,
2242.9  1636.5 mg/day and 1.8  1.0, respectively. Nor-
motensive and prehypertensive participants had no signiﬁ-
cant differences in the mean dietary and urinary Na, K
and Na/K ratio (P > 0.05). However, the mean age, SBP,
DBP, BMI (all P < 0.001) and UCr (P = 0.003) were signiﬁ-
cantly higher in prehypertensive subjects than in normoten-
sive participants. Moreover, prehypertension was
marginally signiﬁcant more frequently in men than in
women (P = 0.05). Normotensive and prehypertensive par-
ticipants had non-signiﬁcant differences in terms of nuts
and seeds, fruits and vegetables, fast food, dairy products,
canned food, salty snacks, processed meat, sweats and soft
drinks (P > 0.05); however, only grain consumption was
signiﬁcantly more in prehypertensive versus normotensive
(P = 0.040).
The main sources of Na intake were table and cooking
salt, grains, cheese, fruits and vegetables, other dairy pro-
ducts, meats, fast foods, sweets and soft drinks, salty
snacks, canned foods and nuts and seeds (Table 2). There
was a non-signiﬁcant difference between sources of Na
intake in normotensive and prehypertensive participants
(P > 0.05). The mean SBP and DBP were not signiﬁcantly
related with urinary and dietary Na and K levels (P > 0.05)
(Table 3). However, SBP and DBP signiﬁcantly increased
with higher dietary Na/K ratio (P = 0.006 and 0.039,
respectively) and UNa/UK ratio (P < 0.001 and 0.003,
respectively).
According to the obtained ORs (95% conﬁdence interval
(CI)) for the crude and adjusted models, there were no
Table 1 Basic characteristics of participants according to blood pressure
Total Normotensive Prehypertensive P-value(a)
Age (years) 38.9  11.4 37.8  11.0 43.6  11.7 <0.001
Gender (male) (%) 349 (43.3) 309 (42.2) 40 (54.1) 0.050
Dietary sodium (mg/day) 4309.6  1344.4 4309.9  1366.9 4308.2  1240.6 0.989
Dietary potassium (mg/day) 2732.7  1050.5 2710.8  1049.0 2832.6  1055.2 0.208
Dietary sodium to potassium ratio 1.6  0.8 1.6  0.9 1.5  0.8 0.409
24-hour urine sodium (mg/day) 4069.6  1655.3 4070.6  1684.4 4065.3  1521.1 0.973
24-hour urine potassium (mg/day) 2242.9  1636.5 2202.7  1609.7 2125.8  1547.6 0.335
24-hour urine sodium to potassium ratio 1.8  1.0 1.8  1.0 1.9  0.9 0.264
Systolic blood pressure (mmHg) 112.0  10.9 108.9  8.5 126.2  9.2 <0.001
Diastolic blood pressure (mmHg) 70.8  8.7 68.1  6.5 83.5  5.7 <0.001
Body mass index (kg/m2) 25.7  4.4 25.4  4.5 28.4  4.5 <0.001
24-hour urine creatinine (mg/day) 1611.8  555.4 1585.32  557.4 1732.5  531.6 0.003
Dietary intake (g/day):
Grains 358.6  132.1 353.0  150.6 374.6  157.4 0.040
Nuts and seeds 7.6  10.2 7.6  7.9 7.2  9.5 0.675
Fruits and vegetables 298.2  165.1 294.8  186.5 314.3  141.5 0.151
Fast food 33.9  30.5 33.8  30.9 34.5  29.7 0.176
Dairy products 362.0  218.9 356.5  211.3 387.3  250.1 0.171
Canned food 7.3  10.2 7.5  10.3 6.6  8.3 0.483
Salty snacks 5.1  4.2 5.4  4.5 3.7  7.6 0.064
Processed meat 8.9  6.7 8.9  7.0 8.7  6.9 0.231
Sweats and soft drinks 138.1  114.2 139.0  119.2 136.3  126.6 0.623
(a) P-value: comparison between normotensive and prehypertensive participants.
Association of Na and K intake with blood pressure
© 2016 Dietitians Association of Australia 3
signiﬁcant relationships between dietary Na and K levels
and Na/K ratio except for the OR (95% CI) of the highest
quartile of dietary Na/K ratio against reference in the fully
adjusted model (OR (95% CI): 1.28 (1.01–1.57); P for
trend = 0.046) (Table 4).
As seen in Table 5, OR (95% CI) of the crude model in
the highest quartile of UNa indicated a signiﬁcant associa-
tion with the higher risk of prehypertension (OR (95% CI):
2.09 (1.09–4.05); P for trend = 0.007). The OR increased
in Model 1 with adjustment for age and gender (OR (95%
CI): 2.35 (1.17–4.71); P for trend = 0.005). The ORs in
Model 2 with additional adjustment for BMI and Model
3 with additional adjustment for UCr were not signiﬁcantly
related to UNa levels in the second, third and fourth quar-
tiles compared to the ﬁrst quartile. However, the trend of
ORs in these models showed a signiﬁcant increase (P for
tend = 0.033 and 0.045, respectively). Nevertheless, there
were non-signiﬁcant associations between prehypertension
and UK in the crude and multivariate models (Table 5).
The OR of prehypertension was not signiﬁcantly associated
with the UNa/UK ratio in the crude model and the model
adjusted for age and gender (model 1). In contrast, the OR
(95% CI) of UNa/UK ratio in the Model 2 with additional
adjustment for BMI was signiﬁcantly associated with a
higher risk of prehypertension in the highest quartile of the
UNa/UK ratio (OR (95% CI): 2.14(1.01–4.55); P for
trend = 0.030). Similar results were seen in Model 3 with
additional adjustment for UCr (OR (95% CI): 2.15
(1.08–4.55); P for trend = 0.029) (Table 5).
Discussion
There was a signiﬁcant positive association between dietary
Na/K ratio and prehypertension in the fully adjusted model.
The present study also showed signiﬁcant positive
Table 2 Food contribution in sodium intake according to blood pressure
Food item (%) Total Normotensive Prehypertensive P-value(a)
Salt at table and preparing food 48.8  14.1 49.1  13.9 48.4  14.9 0.594
Grains 18.1  7.8 18.1  7.9 18.3  7.7 0.723
Cheese 8.8  6.2 8.5  5.9 9.2  7.3 0.327
Fruits and vegetables 7.3  3.5 7.3  3.9 8.7  7.9 0.867
Other dairy products 6.1  3.8 6.1  3.7 6.5  4.1 0.258
Meats 3.8  2.5 3.8  2.6 3.7  2.0 0.739
Fast food 2.1  3.1 2.1  3.1 2.1  3.0 0.857
Sweats and soft drinks 1.6  1.8 1.6  1.9 1.5  1.7 0.316
Salty snacks 0.8  1.4 0.8  1.4 0.6  1.2 0.143
Canned food 0.5  1.0 0.5  1.0 0.5  0.9 0.873
Nuts and seeds 0.1  0.4 0.1  .0.4 0.1  0.5 0.416
Others 1.5  1.9 1.9  1.9 1.0  1.2 0.129
(a) P-value: comparison between normotensive and prehypertensive participants by the Mann–Whitney U test.
Table 3 Mean blood pressures based on quartiles of dietary and urinary sodium, potassium and sodium to potassium ratio
Q1 Q2 Q3 Q4 P-value(a)
Quartile of sodium intake <3270 3270–4083 4084–5256 >5256
Systolic blood pressure (mmHg) 111.7  10.6 112.7  11.6 111.3  10.9 112.3  10.1 0.569
Diastolic blood pressure (mmHg) 70.8  9.1 71.2  8.7 70.4  8.5 71.0  8.3 0.233
Quartile of potassium intake <2008 2008–2549 2550–3198 >3198
Systolic blood pressure (mmHg) 111.8  11.5 112.3  9.8 111.1  10.4 112.8  11.6 0.344
Diastolic blood pressure (mmHg) 71.1  9.3 69.9  8.0 70.9  8.6 71.5  8.6 0.213
Quartile of sodium to potassium ratio intake <1.22 1.22–1.59 1.60–2.03 >2.03
Systolic blood pressure (mmHg) 109.8  10.8 112.9  10.9 112.0  10.7 113.2  10.4 0.006
Diastolic blood pressure (mmHg) 69.4  9.4 71.4  8.4 71.0  8.7 71.6  10.4 0.039
Quartile of urinary sodium <2865 2865–3780 3781–5011 >5011
Systolic blood pressure (mmHg) 112.9  12.3 111.6  11.1 111.6  9.8 111.2  10.4 0.594
Diastolic blood pressure (mmHg) 69.7  8.1 70.9  8.2 71.2  9.1 71.3  9.3 0.202
Quartile of urinary potassium <1474 1474–2008 2009–2626 >2626
Systolic blood pressure (mmHg) 112.9  10.7 111.6  10.8 112.7  10.4 111.8  11.9 0.341
Diastolic blood pressure (mmHg) 70.8  8.2 69.5  7.8 71.6  8.7 71.0  8.8 0.247
Quartile of urinary sodium to potassium ratio <1.39 1.39–1.87 1.88–2.63 >2.63
Systolic blood pressure (mmHg) 109.2  11.0 112.1  10.6 112.6  11.6 114.0  9.8 <0.001
Diastolic blood pressure (mmHg) 69.2  9.0 71.1  7.8 70.7  8.7 72.4  7.9 0.003
(a) P-value: for parametric analysis, ANOVA test and for nonparametric analysis, Kruskal–Wallis test was used.
N. Mohammadifard et al.
4 © 2016 Dietitians Association of Australia
relationships of BP with both UNa and UNa/UK ratio,
which are a proxy for unhealthy diet after adjustment for
potential confounders such as age, gender, BMI and UCr.
However, there was no signiﬁcant association between K
and BP. Moreover, SBP and DBP signiﬁcantly increased
with increasing dietary and urinary Na/K ratios.
Similar to our ﬁndings, large-scale observational studies
such as INTERSALT,19 European Prospective Investigation
into Cancer in Norfolk20 and Prospective Urban Rural Epi-
demiological Study, as well as some recent meta-analyses of
RCTs, illustrated a positive relationship between Na and BP
that was greater in hypertensive than normotensive
populations.22–26 Other population-based studies reported
that reducing Na intake could reduce BP in both hyperten-
sive and normotensive adults.11,27,28
The evidence regarding the association between K intake
and BP is inconsistent. Contrary to our ﬁndings, several
epidemiological and clinical trials indicated an inverse rela-
tionship between dietary K intake and BP.20,27–29 The
INTERSALT study showed a negative association between
UK and BP in a large population from around the world.20
Several double-blind RCTs reported that reducing K intake
increased BP in both hypertensive and normotensive
participants.20,27–29 Moreover, Siani et al. concluded that a
Table 4 Odds ratios (95% CI) of prehypertension based on quartiles of dietary sodium, potassium and sodium to potassium
ratio
P for trend
Quartiles of sodium intake
Crude model 1 1.29 (0.76–2.20) 1.66 (0.99–2.79) 1.21 (0.70–2.07) 0.052
Model 1(a) 1 1.21 (0.69–2.12) 1.50 (0.87–2.60) 1.13 (0.64–1.99) 0.105
Model 2(b) 1 1.21 (0.69–2.13) 1.50 (0.87–2.60) 1.13 (0.64–1.99) 0.112
Model 3(c) 1 1.17 (0.66–2.05) 1.48 (0.85–2.56) 1.11 (0.63–1.97) 0.115
Quartiles of potassium intake
Crude model 1 0.75 (0.45–1.23) 0.87 (0.52–1.40) 0.79 (0.35–1.12) 0.161
Model 1(a) 1 0.79 (0.46–1.33) 0.85 (0.51–1.43) 0.76 (0.32–1.09) 0.129
Model 2(b) 1 0.78 (0.46–1.33) 0.85 (0.51–1.43) 0.76 (0.32–1.08) 0.125
Model 3(c) 1 0.78 (0.46–1.32) 0.87 (0.52–1.47) 0.77 (0.33–1.09) 0.131
Quartile of sodium to potassium ratio intake
Crude model 1 1.18 (0.91–1.50) 1.13 (0.89–1.46) 1.19 (0.94–1.51) 0.123
Model 1(a) 1 1.20 (0.92–1.53) 1.15 (0.88–1.45) 1.22 (0.95–1.53) 0.116
Model 2(b) 1 1.24 (0.95–1.54) 1.21(0.92–1.51) 1.25 (0.97–1.56) 0.105
Model 3(c) 1 1.26 (0.97–1.56) 1.23 (0.95–1.52) 1.28 (1.01–1.57) 0.046
(a) Model 1: adjustment for age and gender.
(b) Model 2: additional adjustment for body mass index.
(c) Model 3: additional adjustment for 24-hour urinary creatinine.
Table 5 Odds ratios (95% CI) of prehypertension based on quartiles of urinary sodium, potassium and sodium to potassium
ratio
P for trend
Quartiles of sodium
Crude model 1 0.79(0.36–1.73) 1.20(0.59–2.45) 2.09(1.09–4.05) 0.007
Model 1(a) 1 0.89(0.39–1.99) 1.25(0.59–2.65) 2.35(1.17–4.71) 0.005
Model 2(b) 1 0.89(0.38–2.04) 1.15(0.52–2.56) 1.98(0.94–4.16) 0.033
Model 3(c) 1 0.85(0.37–1.96) 1.12(0.50–2.49) 1.89(0.89–3.97) 0.045
Quartiles of potassium
Crude model 1 1.01(0.51–2.03) 0.88(0.43–1.82) 1.39(0.73–2.69) 0.318
Model 1(a) 1 0.82(0.40–1.69) 0.70(0.33–1.50) 1.11(0.56–2.18) 0.683
Model 2(b) 1 0.64(0.30–1.37) 0.49(0.22–1.12) 0.74(0.35–1.55) 0.564
Model 3(c) 1 0.63(0.29–1.37) 0.47(0.21–1.07) 0.68(0.32–1.46) 0.440
Quartile of sodium to potassium ratio
Crude model 1 0.99(0.48–2.05) 1.19(0.59–2.39) 1.49(0.76–2.93) 0.176
Model 1(a) 1 1.04(0.49–2.21) 1.35(0.66–2.79) 1.87(0.93–3.77) 0.051
Model 2(b) 1 1.02(0.46–2.25) 1.33(0.63–2.80) 2.14(1.01–4.55) 0.030
Model 3(c) 1 1.00(0.45–2.21) 1.31(0.62–2.77) 2.15(1.08–4.55) 0.029
(a) Model 1: adjustment for age and gender.
(b) Model 2: additional adjustment for body mass index.
(c) Model 3: additional adjustment for 24-hour urinary creatinine.
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high-K diet decreased the need for antihypertensive medica-
tions in patients with normal renal function.30
Appel et al. suggested that the high natural K content of
fruits and vegetables in combination with low Na intake,
according to the Dietary Approach to Stop Hypertension
(DASH), reduced SBP and DBP in both hypertensive and nor-
motensive participants.31 However, the exact role of K in the
beneﬁcial effects of DASH cannot be determined as the anti-
oxidant content of fruits and vegetables might actually be
responsible for BP reduction.32 Nevertheless, a recent meta-
analysis incorporating 22 RCTs reported that a K supplement
reduced BP only in adults with primary hypertension.10 One
former meta-analysis including 33 RCTs found that the bene-
ﬁcial effect of dietary K supplementation on SBP and DBP
remained in participants with high salt intake.33 Therefore, K
supplementation can be recommended as an appropriate
strategy to decrease BP in hypertensive patients who cannot
reduce their salt intake.31 In fact, K intake can, to some
extent, blunt the undesirable effects of high Na intake.34
However, a systematic review on six RCTs conﬁrmed
our ﬁndings and indicated that dietary K supplementation
had no signiﬁcant effects on SBP and DBP.35
Several potential reasons, including various polymorph-
isms in some relevant genes and maternal hypertension his-
tory, may lead to different reactions of persons to dietary K
intake.36,37 Furthermore, in most previous studies, few parti-
cipants had stage II hypertension. In the present study, how-
ever, no individuals with mild hypertension (SBP and DBP of
140–159 and 90–99 mmHg, respectively) were included.
Finally, using the most valid biomarker of Na and K intake
in the present study has probably increased the accuracy of
our estimations compared to those in previous studies.
Consistent with the ﬁndings of previous studies,14,38,39
the present study showed the incidence of prehypertension
to be more strongly related with the UNa/K ratio than with
either UNa or UK alone. We found that the OR of prehy-
pertension occurrence was more than doubled in the high-
est quintile of the UNa/K ratio compared to its lowest
quintile. Likewise, the National Health and Nutrition Exam-
ination Survey (2001–2006) and another population-based
study reported that while the combination of Na and K had
a positive relationship with the risk of elevated BP, no such
relationships were present in case of Na and K alone.14,39
The average Na intake in the present study (167 mEq/
day) was about two times higher than the 88 mEq/day
(2000 mg/day) recommended by the WHO.40 Moreover,
the average K intake (63 mEq/day) among our participants
was slightly lower than the recommended amount
(2700–3100 mg/day).40
In the present study, the dietary Na/K ratio were 1.6 and
1.5 in normotensive and prehypertensive subjects and
UNa/UK ratios were 1.8 and 1.9 in normotensive and prehy-
pertensive participants, respectively. This ratio was 1.65 in
the North American population6 and 1.79 in Brazilian
adults.34 However, much lower values (about 0.06) were
reported in the past decades.41 Therefore, changes in dietary
habits along with the adoption of the Western diet, includ-
ing reﬁned and processed foods, provide huge amounts of
salt consumption and decreased their dietary K intake. Such
changes will undoubtedly exert adverse health effects.42,43
High Na intake may not only thicken and narrow the resist-
ance arteries but also inhibit nitric oxide production and
release sympathetic systems. These mechanisms will raise BP
and lead to the development of hypertension.44 While the
mechanism through which K intake decreases BP is still
unclear, induction of nitric oxide synthesis by increasing
intracellular K content might be responsible for this effect.44
The strengths of the present study were using 24-hour
urine collection as the standard approach for the measure-
ment of Na and K intake. To the best of our knowledge,
this was the ﬁrst study in Iran and the Middle East to exam-
ine the associations of BP with not only Na and K intake
but also 24-hour UNa and UK, which surrogate Na and K
intakes in subjects without a diagnosis of hypertension.
As urine samples of a particular day may not accurately
reﬂect one’s usual dietary habits, collecting urine samples
on a single day can be regarded as a limitation of the cur-
rent research. Moreover, because of its cross-sectional
design, the present study might have been unable to clarify
the causality effect.
In conclusion, this population-based cross-sectional
study showed elevated BP and prehypertension to be signif-
icantly related with increased dietary Na/K ratio, UNa and
UNa/K ratio, which can be considered to be surrogates of
an unhealthy diet. However, we failed to ﬁnd signiﬁcant
relationships between BP and dietary Na, K and UK alone.
Further clinical trials are thus warranted to investigate the
causality effects of dietary Na and K intake on BP. Our ﬁnd-
ings supported the need for the development of a salt
reduction programme in Iran.
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